@article{10889,
  keywords = {Cardiovascular disease, Cohort study, drug utilization, glucose-lowering medications, pharmacoepidemiology, Type 2 diabetes},
  author = {D. Abrahami and E. D'Andrea and H. Yin and S. Kim and J. Paik and D. Wexler and L. Azoulay and E. Patorno},
  title = {Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom},
  year = {2023},
  journal = {Diabetes Obes Metab},
  edition = {2023/07/03},
  isbn = {1462-8902},
  doi = {10.1111/dom.15196},
  note = {1463-1326
Abrahami, Devin
D'Andrea, Elvira
Yin, Hui
Kim, Seoyoung C
Paik, Julie M
Wexler, Deborah
Azoulay, Laurent
Orcid: 0000-0001-5162-3556
Patorno, Elisabetta
Orcid: 0000-0002-8809-9898
K08AG055670/AG/NIA NIH HHS/United States
5U01FD007213/FD/FDA HHS/United States
Journal Article
England
Diabetes Obes Metab. 2023 Jul 3. doi: 10.1111/dom.15196.},
  language = {eng},
}